Press release
Global Growth Hormone Deficiency Market to Reach $5.42 Billion by 2029, Growing at 5.9% CAGR
Growth Hormone Deficiency
The increasing prevalence of genetic disorders is projected to drive the growth of the growth hormone deficiency market. Genetic disorders are caused by mutations or abnormalities in an individual's DNA, either inherited or spontaneous. Factors such as advancements in diagnostic technology, greater awareness, rising maternal age, environmental influences, population growth, and improved survival rates for affected individuals are contributing to the growing prevalence of genetic disorders. Growth hormone deficiency treatments are particularly relevant for managing growth-related complications in certain genetic conditions. A report from the Department of Health & Social Care in December 2022 revealed that by October 2022, approximately 33,000 whole genome equivalents were sequenced, with a diagnostic yield of 32%, increasing to 61% for specific conditions. As the prevalence of genetic disorders continues to grow, the growth hormone deficiency market will expand.
Get Your Growth Hormone Deficiency Market Report Here:
https://www.thebusinessresearchcompany.com/report/growth-hormone-deficiency-global-market-report
How will the growth rate of the growth hormone deficiency market shape industry trends by 2034?
The growth hormone deficiency market has expanded strongly, growing from $4.06 billion in 2024 to $4.31 billion in 2025 at a CAGR of 6.1%. Growth has been driven by increased strategic initiatives, rising incidences of brain tumors, growing demand for hormone therapies, an aging population, and higher government healthcare funding.
The growth hormone deficiency market size is anticipated to witness substantial growth in the next few years. By 2029, it is projected to reach $5.42 billion, growing at a CAGR of 5.9%. Factors contributing to this growth include the increasing prevalence of genetic disorders, a rise in strategic initiatives, increased investment in research and development, a growing number of GH disease cases, and an increase in clinical trials. Notable trends in the forecast period include technological advancements, expansion of treatment options, improvements in diagnostic techniques, recent innovations, and progress in biotechnology.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21197&type=smp
What trends are poised to drive the future success of the growth hormone deficiency market?
In the growth hormone deficiency (GHD) market, companies are focusing on more convenient treatment options, such as unmodified somatropin, for pediatric GHD patients. This growth hormone is typically administered daily but is now offered as a once-weekly treatment in the form of Skytrofa (lonapegsomatropin). In September 2023, Ascendis Pharma A/S, a Denmark-based biopharmaceutical company, launched Skytrofa as the first FDA-approved once-weekly treatment for pediatric GHD. This innovative therapy aims to improve patient adherence and convenience while potentially delivering better treatment outcomes compared to traditional daily growth hormone therapies.
Which primary segments of the growth hormone deficiency market are driving growth and industry transformations?
The growth hormone deficiency market covered in this report is segmented -
1) By Type: Pediatric Growth Hormone Deficiency, Adult Growth Hormone Deficiency
2) By Treatment: Pharmacological Therapy, Recombinant Human Growth Hormone, Human Pituitary Gland Extracts, Surgery
3) By Route Of Administration: Intravenous, Intramuscular, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Pediatric Growth Hormone Deficiency: Idiopathic Growth Hormone Deficiency, Genetic Growth Hormone Deficiency, Acquired Growth Hormone Deficiency
2) By Adult Growth Hormone Deficiency: Primary Growth Hormone Deficiency, Secondary Growth Hormone Deficiency
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21197
Which geographical regions are pioneering growth in the growth hormone deficiency market?
North America was the largest region in the growth hormone deficiency market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the growth hormone deficiency market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the influential players reshaping the growth hormone deficiency market landscape?
Major companies operating in the growth hormone deficiency market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, AbbVie Inc., Eli Lilly and Company, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Genentech Inc., Ipsen Biopharmaceuticals Inc., Opko Health Inc., JCR Pharmaceuticals Co. Ltd., Ferring Pharmaceuticals Inc., Ascendis Pharma A/S, Rani Therapeutics Inc., AnkeBio Co. Ltd., Aeterna Zentaris Inc., Zhongshan Sinobioway Hygene Biomedicine Co. Ltd., Versartis Inc., I-Mab Biopharma Co. Ltd.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21197&type=smp
What Is Covered In The Growth Hormone Deficiency Global Market Report?
•Market Size Forecast: Examine the growth hormone deficiency market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the growth hormone deficiency market for a structured understanding.
•Key Players Overview: Analyze major players in the growth hormone deficiency market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the growth hormone deficiency market.
•Segment Contributions: Evaluate how different segments drive overall growth in the growth hormone deficiency market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the growth hormone deficiency market.
•Industry Challenges: Identify potential risks and obstacles affecting the growth hormone deficiency market.
•Competitive Landscape: Review strategic developments in the growth hormone deficiency market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Growth Hormone Deficiency Market to Reach $5.42 Billion by 2029, Growing at 5.9% CAGR here
News-ID: 3936347 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Hormone
Surge In Hormone Imbalance Disorders Fuels Growth Of Hormone Therapy Market Emer …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Is the Expected CAGR for the Hormone Therapy Market Through 2025?
The size of the hormone therapy market has experienced significant growth in the past few years. It is expected to increase from $19.7 billion in 2024 to $21.1 billion in 2025, at a compound annual growth rate (CAGR) of 7.1%. The growth…
Parathyroid Hormone Market Overview: How Parathyroid Hormone Affects Health & Cl …
Parathyroid Hormone Market is predicted to grow at a CAGR 3.4% during the forecast period (2024-2031).
Parathyroid Hormone Market Report by DataM Intelligence delivers deep insights and analysis into the latest market trends, growth opportunities, and emerging challenges. Designed to help businesses make smarter, faster decisions, our reports combine both data-driven analysis and expert perspectives. At DataM Intelligence, we're committed to turning complex market landscapes into clear, actionable strategies so…
Estrogen Hormone Replacement: A Vital Segment Driving Growth in the Hormone Repl …
The Hormone Replacement Therapy (HRT) market is experiencing renewed interest, driven by an aging population and a growing understanding of hormonal health. Within this market, the estrogen hormone replacement segment stands out as a high-opportunity area, offering relief from menopausal symptoms and addressing various health concerns.
Market Dynamics and Growth Drivers
Estrogen HRT plays a crucial role in managing menopausal symptoms, such as hot flashes, night sweats, and vaginal dryness. Beyond symptom…
Klinefelter Syndrome Hormone Therapy Market - Balancing Hormones, Unleashing Pot …
Newark, New Castle, USA: The "Klinefelter Syndrome Hormone Therapy Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Klinefelter Syndrome Hormone Therapy Market: https://www.growthplusreports.com/report/klinefelter-syndrome-hormone-therapy-market/8775
This latest report researches the…
Human Growth Hormone Market - Elevating Lives, Amplifying Growth: Innovations in …
Newark, New Castle, USA - new report, titled Human Growth Hormone Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Human Growth Hormone market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Human Growth Hormone market. The report offers an overview of…
Hormone Replacement Therapy Market Report- Segment by Application Menopause, Hyp …
The Hormone Replacement Therapy Market research report presents an intensive and coordinated exploration of the current circumstance, market key elements, Hormone Replacement Therapy Market methodologies, and central participants' development in the business. The investigation helps controllers and corporate leaders in developing cost-effective decisions. Hormone Replacement Therapy Market provides an evenhanded and extensive assessment of existing examples, factors, obstacles, limits, headway, possibilities/quick development areas that will help partners create business plans…
